What is Faeth Therapeutics, Inc.?
, a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients.
The story behind the price, the case for and against, and what could go wrong. Open a part to read it.
, a clinical-stage biotechnology company, engages in the discovery and development of therapeutics for cancer patients. The company offers PIKTOR, an investigational multi-node inhibitor of the PI3K/AKT/mTOR pathway in development for endometrial and breast cancer. The company is listed on the NASDAQ in USA, operating in the Healthcare sector, with a market capitalisation of 203.65M.
A short list of Biotechnology names that are close enough in size to make side-by-side comparison useful.